A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer

The role of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKIs) in improving the prognostic outcome of non-small cell lung cancer (NSCLC) cases harboring EGFR mutation following radical surgery is still controversial. This work focused on comparing EGFR-TKIs and adjuvant chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Ran, Wei, Chun, Li, Xianyi, Jiang, Ou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704950/
https://www.ncbi.nlm.nih.gov/pubmed/36451449
http://dx.doi.org/10.1097/MD.0000000000031894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704950/
https://www.ncbi.nlm.nih.gov/pubmed/36451449
http://dx.doi.org/10.1097/MD.0000000000031894

Ejemplares similares